Device-related complications in the subcutaneous and transvenous ICD: a secondary analysis of the PRAETORIAN trial.
Reinoud E KnopsShari PepplinkhuizenPeter Paul H M DelnoyLucas V A BoersmaJuergen KuschykMikhael F El-ChamiHendrik BonnemeierElijah R BehrTom F BrouwerStefan KaabSuneet MittalAnne Floor B E QuastWilleke van der StuijtLonneke SmedingJolien A de VeldJan G P TijssenNick R BijsterveldSergio RichterMarc A BrouwerJoris R de GrootKirsten M KooimanPier D LambiasePetr NeuzilKevin VernooyMarco AlingsTimothy R BettsFrank A L E BrackeMartin C BurkeJonas S S G de JongDavid J WrightWard P J JansenZachary I WhinnettPeter NordbeckMichael KnautBerit T PhilbertJurren M van OpstalAlexandru B ChicosCornelis P AllaartAlida E Borger van der BurgJose M DizonMarc A MillerDmitry NemirovskyRalf SurberGaurav A UpadhyayRaul WeissAnouk de WegerArthur A M WildeLouise R A Olde NordkampPublished in: European heart journal (2022)
This secondary analysis shows that, lead-related complications and systemic infections are more prevalent in the TV-ICD group compared to the S-ICD group. In addition, complications in the TV-ICD group were more severe as they required significantly more invasive interventions. This data contributes to shared decision making in clinical practice.